No Data
No Data
Medexus Pharmaceuticals Inc Raised to Strong Buy From Outperform by Raymond James
Stifel Nicolaus Keeps Their Buy Rating on Medexus Pharmaceuticals Inc (MDP)
Medexus Pharmaceuticals Inc Raised to Outperform From Market Perform by Raymond James
Medexus and Pan-Canadian Pharmaceutical Alliance (PCPA) Successfully Complete Negotiations for Trecondyv (Treosulfan for Injection) in Canada
Should We Be Cautious About Medexus Pharmaceuticals Inc.'s (TSE:MDP) ROE Of 7.0%?
Medexus Pharmaceuticals Inc. (MEDXF) Q2 2025 Earnings Call Transcript Summary